Urokinase receptor is a multifunctional protein: Influence of receptor occupancy on macrophage gene expression

Journal of Clinical Investigation

Volumn 96, Issue 1, 1995, Pages 465-474

  Rao, Navaneetha K ^a,b   Shi, Guo Ping ^a,b   Chapman, Harold A ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

gene expression; macrophage; urokinase receptor

Indexed keywords

CATHEPSIN B; GELATINASE; UROKINASE;

ARTICLE; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR OCCUPANCY;

EID: 0029113231     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118057     Document Type: Article

References (73)

1. Rovera, G., D. Santoli, and C. Damsky. 1979. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA. 76:2779-2783.
2. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer. 17:565-577.
3. Hass, R. 1992. Retrodifferentiation - an alternative biological pathway in human leukemia cells. Eur. J. Cell Biol. 58:1-11.
4. Welgus, H. G., N. L. Connolly, and R. M. Senior. 1986. 12-o-Tetradecanoylphorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases: high levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. J. Clin. Invest. 77:1675-1681.
5. Gross, T. J., and R. G. Sitrin. 1990. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. J. Immunol. 144:1873-1879.
6. Burnett, D., J. Crocker, and A. T. M. Vaughan. 1983. Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukaemia cell line. J. Cell. Physiol. 115:249-254.
7. Welgus, H. G., E. J. Campbell, J. D. Cury, A. Z. Eisen, R. M. Senior, S. M. Wilhelm, and G. I. Goldberg. 1990. Neutral metalloproteinases produced by human mononuclear phagocytes-enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86:1496-1502.
8. Stein, M., T. Braulke, K. V. Figura, and A. Hasilik. 1987. Effects of differentiation-inducing agents on synthesis, maturation and secretion of cathepsin D in U937 and HL-60 cells. Biol. Chem. Hoppe-Seyler. 368:413-418.
9. Campbell, E. J., J. D. Cury, S. D. Shapiro, G. I. Goldberg, and H. G. Welgus. 1991. Neutral proteinases of human mononuclear phagocytes - cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol. 146:1286-1293.
10. Hanson, R. D., N. L. Connolly, D. Burnett, E. J. Campbell, R. M. Senior, and T. J. Ley. 1990. Developmental regulation of the human cathepsin G gene in myelomonocytic cells. J. Biol. Chem. 265:1524-1530.
11. Watanabe, H., I. Nakanishi, K. Yamashita, T. Hayakawa, and Y. Okada. 1993. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell. Sci. 104:991-999.
12. Stoppelli, M. P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R. K. Assoian. 1985. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA. 82:4939-4943.
13. Picone, R., E. L. Kajtaniak, L. S. Nielsen, N. Behrendt, M. R. Mastronicola, M. V. Cubellis, M. P. Stoppelli, S. Pedersen, K. Dano, and F. Blasi. 1989. Regulation of urokinase receptors in monocyte-like U937 cells by phorbol ester, phorbol myristate acetate. J. Cell Biol. 108:693-702.
14. Lund, L. R., E. Ronne, A. L. Roldan, N. Behrendt, J. Romer, F. Blasi, and K. Dano. 1991. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J. Biol. Chem. 266:5177-5181.
15. Plow, E. F., D. E. Freaney, J. Plescia, and L. A. Miles. 1986. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103:2411-2420.
16. Ellis, V., M. F. Scully, and V. V. Kakkar. 1989. Plasminogen activation initiated by single chain urokinase-type plasminogen activator: potentiation by U937 cells. J. Biol. Chem. 264:2185-2188.
17. Alexander, C. M., and Z. Werb. 1989. Proteinases and extracellular matrix remodeling. Curr. Opin. Cell Biol. 1:974-982.
18. Nusrat, A. R., and H. A. Chapman. 1991. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87:1091-1097.
19. Waltz, D. A., L. Z. Sailor, and H. A. Chapman. 1993. Cytokines induce urokinase-dependent adhesion of human myeloid cells: A regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91:1541-1552.
20. Waltz, D. A., and H. A. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269:14746-14750.
21. Wei, Y., D. A. Waltz, N. Rao, R. J. Drummond, S. Rosenberg, and H. A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
22. Haskill, S., C. Johnson, D. Eierman, S. Becker. and K. Warren. 1988. Adherence induces selective mRNA expression of monocyte mediators and protooncogenes. J. Immunol. 140:1690-1694.
23. Eierman, D. F., C. E. Johnson, and J. S. Haskill. 1989. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J. Immunol. 142:1970-1976.
24. Stefanova, I., V. Horejsi, I. J. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-Anchored cell-surface molecules complexed to protein tyrosine kinases. Science (Wash. DC). 254:1016-1019.
25. Ip, N. Y., S. H. Nye, T. G. Boulton, S. Davis, T. Taga, Y. Li, S. J. Birren, K. Yasukawa, T. Kishimoto, D. J. Anderson, N. Stahl, and G. D. Yancopoulos. 1992. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell. 69:1121-1132.
26. He, C.-J., J.-M. Rebibou, M.-N. Peraldi, Q. Meulders, and E. Rondeau. 1991. Growth factor-like effect of urokinase type plasminogen activator in human renal cells. Biochem. Biophys. Res. Commun. 176:1408-1416.
27. Kirchheimer, J. C., G. Christ, and B. R. Binder. 1989. Growth stimulation of human epidermal cell by urokinase is restricted to the intact active enzyme. Eur. J. Biochem. 181:103-107.
28. Rabbani, S. A., A. P. Mazar, S. M. Bernier, M. Haq, I. Bolivar, J. Henkin, and D. Goltzman. 1992. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267:14151-14156.
29. Del Rosso, M., E. Anichini, N. Pedersen, F. Blasi, G. Fibbi, M. Pucci, and M. Ruggiero. 1993. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem. Biophys. Res. Commun. 190:347-352.
30. Busso, N., S. K. Masur, D. Lazega, S. Waxman, and L. Ossowski. 1994. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126:259-270.
31. Ways, D. K., R. C. Dodd, T. E. Bennett, T. K. Gray, and H. S. Earp. 1987. 1,25-Dihydroxyvitamin D3 enhances phorbol ester-stimulated differentiation and protein kinase C-dependent substrate phosphorylation activity in U937 human monoblastoid cell. Endocrinology. 121:1654-1661.
32. Bordier, C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1604-1607.
33. Estreicher, A., A. Wohlwend, D. Belin, W.-D. Schleuning, and J.-D. Vassalli. 1989. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem. 264:1180-1189.
34. Chapman, H. A., P. Bertozzi, L. Z. Sailor, and A. R. Nusrat. 1990. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface. Am. J. Physiol. 259:L432-L438.
35. Sitrin, R. G., R. F. Todd, I. F. Mizukami, T. J. Gross, S. B. Shollenberger, and M. R. Gyetko. 1994. Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood. 84:1268-1275.
36. Shi, G.-P., J. S. Munger, J. P. Meara, D. H. Rich, and H. A. Chapman. 1992. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:7258-7262.
37. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
38. Nedwin, G. E., L. P. Svedersky, T. S. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Effect of interleukin-2, interferon-gamma and mitogens on the production of tumor necrosis factor alpha and beta. J. Immunol. 135:2492-2497.
39. Vernet, T., H. E. Khouri, P. Laflamme, D. C. Tessier, R. Musil, B. J. Gour-Salin, A. C. Storer. and D. Y. Thomas. 1991. Processing of the papain precursor-purification of the zymogen and characterization of its mechanism of processing. J. Biol. Chem. 266:21451-21457.
40. Saksela, O., T. Hovi, and A. Vaheri. 1985. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J. Cell. Physiol. 122:125-132.
41. Kelley, J. L., M. M. Rozek, C. A. Suenram. and C. J. Schwartz. 1987. Activation of human blood monocytes by adherence to tissue culture plastic surfaces. Exp. Mol. Pathol. 46:266-278.
42. Nykjaer, A., C. M. Petersen, E. I. Christensen, O. Davidsen, and J. Gliemann. 1990. Urokinase receptors in human monocytes. Biochim. Biophys. Acta. 1052:399-407.
43. Saarialho-Kere, U. K., H. G. Welgus, and W. C. Parks. 1993. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 268:17354-17361.
44. 2-terminal domain of the urokinase receptor. FEBS (Fed. Eur. Biochem. Soc.) Lett. 288:233-236.
45. Wilhelm, O., U. Weidle, S. Hohl, P. Rettenberger, M. Schmitt, and H. Graeff. 1994. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA) - inhibition of proliferation and invasion of human ovarian cancer cells. FEBS (Fed. Eur. Biochem. Soc.) Lett. 337:131-134.
46. Lisanti, M. P., M. C. Field, I. W. Caras, A. K. Menon, and E. Rodriguez-Boulan. 1991. Mannosamine, a novel inhibitor of glycosylphosphatidylinositol incorporation into proteins. EMBO (Eur. Mol. Biol. Orgn.) J. 10:1969-1977.
47. Sung, S.-S. J., J. A. Walters, J. Hudson, and J. M. Gimble. 1991. Tumor necrosis factor-alpha mRNA accumulation in human myelomonocytic cell lines - role of transcriptional regulation by DNA sequence motifs and mRNA stabilization. J. Immunol. 147:2047-2054.
48. Stephenson, R. P. 1956. A modification of receptor theory. Br. J. Pharm. 11:379-393.
49. Hohmann, H.-P., R. Remy, B. Poschl, and A. P. G. M. v. Loon. 1990. Tumor necrosis factors α and β bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-κB at low receptor occupancy and within minutes after receptor binding. J. Biol. Chem. 265:15183-15188.
50. Wiley, H. S., B. J. Walsh, and K. A. Lund. 1989. Global modulation of the epidermal growth factor receptor is triggered by occupancy of only a few receptors. Evidence for a binary regulatory system in normal human fibroblasts. J. Biol. Chem. 264:18912-18920.
51. Shuman, M. A. 1986. Thrombin-cellular interactions. Ann. N. Y. Acad. Sci. 485:228-239.
52. Coughlin, S. R., T. K. Vu, D. T. Hung, and V. I. Wheaton. 1992. Characterization of a functional thrombin receptor. Issues and opportunities. J. Clin. Invest. 89:351-355.
53. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell. 65:1281-1289.
54. Nykjaer, A., C. M. Petersen, B. Moller, P. H. Jensen, S. K. Moestrup, T. L. Holtet, M. Etzerodt, H. C. Thogersen, M. Munch, P. A. Andreasen, and J. Gliemann. 1992. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267:14543-14546.
55. Gearing, D. P., C. J. Thut, T. VandenBos, S. D. Gimpel, P. B. Delaney, J. King, V. Price, D. Cosman, and M. P. Beckmann. 1991. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp 130. EMBO (Eur. Mol. Biol. Orgn.) J. 10:2839-2848.
56. Lutticken, C., U. M. Wegenka, J. Yuan, J. Buschmann, C. Schindler, A. Ziemiecki, A. G. Harpur, A. F. Wilks, K. Yasukawa, T. Taga et al. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science (Wash. DC). 263:89-92.
57. Glenney, J. R. 1989. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J. Biol. Chem. 264:20163-20166.
58. Glenney, J. R., and D. Soppet. 1992. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. USA. 89:10517-10521.
59. Sargiacomo, M., M. Sudol, Z. Tang, and M. P. Lisanti. 1993. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol. 122:789-807.
60. Mayor, S., K. G. Rothberg, and F. R. Maxfield. 1994. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science (Wash. DC). 264:1948-1951.
61. 2, CD11b/CD18) and FcγRIII cooperate in generation of a neutrophil respiratory burst: requirement for FcγRII and tyrosine phosphorylation. J. Cell Biol. 125:1407-1416.
62. Guinec, N., V. Dalet-Fumeron, and M. Pagano. 1993. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsin B, B-like and L. Biol. Chem. Hoppe-Seyler. 374:1135-1146.
63. Chapman, H. A., J. J. Reilly, and L. Kobzik. 1988. Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages. Am. Rev. Respir. Dis. 137:412-419.
64. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. Bioessays. 14:455-463.
65. Kobayashi, H., N. Moniwa, M. Sugimura, H. Shinohara, H. Ohi, and T. Terao. 1993. Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. Biochim. Biophys. Acta. 1178:55-62.
66. Mignatti, P., and D. B. Rifkin. 1993. Biology and biochemistry of proteinases in tumor invasion. Physiol. Review. 73:161-194.
67. Ossowski, L., and E. Reich. 1983. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 35:611-619.
68. Ossowski, L. 1988. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. J. Cell Biol. 107:2437-2445.
69. Damsky, C. H., and Z. Werb. 1992. Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr. Opin. Cell Biol. 4:772-781.
70. Fibbi, G., M. Ziehe, L. Morbidelli, L. Magnelli, and M. Del-Rosso. 1988. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp. Cell Res. 179:385-395.
71. Gyetko, M. R., R. F. Todd, C. C. Wilkinson, and R. G. Sitrin. 1994. The urokinase receptor is required for human monocyte chemotaxis in vitro. J. Clin. Invest. 93:1380-1387.
72. Ploug, M., T. Plesner, E. Ronne, V. Ellis, G. Hoyer-Hansen, N. E. Hansen, and K. Dano. 1992. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood. 79:1447-1455.
73. Yeh, E. T. H., and W. F. Rosse. 1994. Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor. J. Clin. Invest. 93:2305-2310.